LONG ISLAND CITY, N.Y., Oct. 22, 2025 (GLOBE NEWSWIRE) -- Steven Madden, Ltd. (NASDAQ: SHOO), a leading designer and marketer of fashion-forward footwear, accessories and apparel, today announced that the Company plans to release its third quarter 2025 earnings results on Wednesday, November 5, 2025. Management will host a conference call to review the results at 8:30 a.m. Eastern Time. The live webcast of the management call can be accessed at the Company’s investor relations website at https://investor.st ...

Core Insights - Brightstar Lottery PLC has signed a five-year exclusive licensing agreement with Avanti Licensing, Inc. to develop and distribute omnichannel lottery games based on Avanti's humorous greeting cards [1] - The partnership aims to leverage Avanti's extensive image library and Brightstar's game design expertise to create engaging lottery experiences [1] Company Overview - Brightstar Lottery PLC (NYSE: BRSL) is a global leader in the lottery industry, known for its secure technology and comprehensive solutions [3] - The company employs approximately 6,000 people and is recognized for its integrity and responsibility in lottery operations [3] Partnership Details - Avanti Licensing, Inc. is known for its character-driven greeting cards and has a global presence, with products translated into over 12 languages [1] - The collaboration will focus on creating instant tickets, innovative draw-based games, and engaging eInstant games that reflect Avanti's trademark humor [1]

Core Insights - Descartes Systems Group's inventory and order management solution is significantly enhancing ecommerce growth for CPGIO, allowing the company to scale from 2,000 to 10,000 daily orders by centralizing operations across over 40 sales channels [1][2][3] Company Overview - CPGIO is an omnichannel optimization and fulfillment partner for consumer packaged goods (CPG) companies, focusing on enhancing ecommerce operations and expanding into new markets such as health and beauty [2][4] - Descartes provides software-as-a-service solutions aimed at improving logistics productivity, security, and sustainability, with a global presence and a comprehensive suite of services for logistics-intensive businesses [5] Technology and Solutions - The Descartes Sellercloud™ solution centralizes management of listings, inventory, orders, purchasing, fulfillment, and shipping, featuring over 350 integrations with major marketplaces like Amazon, Walmart, and Shopify [2][3] - CPGIO utilizes Descartes' solution to streamline catalog management, enhance fulfillment workflows, and maintain competitive pricing by calculating net costs through custom workflows [2][3] Market Position - CPGIO serves over 600 leading CPG brands and aims to maintain its status as a top-60 Amazon seller by leveraging Descartes' technology for operational efficiency and market expansion [2][4]

Core Viewpoint - BioNTech has initiated a public exchange offer for all outstanding shares of CureVac, aiming to combine their mRNA technologies to enhance cancer immunotherapy development [1][2]. Group 1: Acquisition Details - The acquisition is structured as an all-stock deal, with each CureVac share valued at approximately $5.46 in BioNTech American Depositary Shares (ADSs), leading to an implied total equity value of around $1.25 billion for CureVac [3]. - The exchange ratio is subject to a collar mechanism, adjusting based on the 10-day volume weighted average price (VWAP) of BioNTech ADSs, with specific ratios set for different price thresholds [3][7]. - The offer is set to expire on December 3, 2025, unless extended or terminated earlier, and requires at least 80% of CureVac's shares to be tendered [5][7]. Group 2: Strategic Objectives - The acquisition is intended to bolster BioNTech's capabilities in research, development, manufacturing, and commercialization of mRNA-based cancer immunotherapies, aligning with its oncology strategy [2][7]. - BioNTech's oncology strategy includes two main programs: mRNA-based cancer immunotherapy candidates and a bispecific antibody candidate, pumitamig (BNT327) [2]. Group 3: Shareholder Participation - CureVac shareholders wishing to participate in the offer are advised to contact their brokers or the information agent, Georgeson LLC, for further details [4][7]. - An extraordinary general meeting (EGM) for CureVac shareholders is scheduled for November 25, 2025, to vote on resolutions related to the transaction and corporate reorganization [8]. Group 4: Regulatory and Compliance - BioNTech has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) regarding the offer, which has not yet become effective [10]. - CureVac's management board recommends that shareholders tender their shares into the offer, as detailed in their filed solicitation/recommendation statement [10].

DUBLIN, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the global settlement of all litigation with Jazz Pharmaceuticals Inc. (“Jazz”). Under the primary terms of the settlement agreement, Avadel and Jazz will dismiss their respective lawsuits with prejudice. Furthermore, Jazz agrees to grant Avadel the following: A perpetual, worldwide license to any past, present, or future paten ...

Core Insights - Biodesix has signed an expanded partnership agreement with Bio-Rad to develop and clinically validate the ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing [1][2][4] - The assay will enable highly sensitive detection and quantification of multiple ESR1 mutations from ctDNA samples, which is critical for HR+/HER2- advanced breast cancer treatment [2][3] - Biodesix plans to offer the validated assay as a test service at its accredited CLIA-CAP laboratory and will seek reimbursement through the Centers for Medicare & Medicaid Services (CMS) [3] Company Developments - The first assay to be validated under the agreement is Bio-Rad's ddPLEX ESR1 Mutation Detection Assay, which is essential for the new generation of therapies known as oral selective estrogen receptor degraders (SERDs) [2] - Biodesix aims to improve clinical care and outcomes for patients through its diagnostic solutions, including the Nodify Lung® Nodule Risk Assessment and IQLung® Cancer Treatment Guidance [5] Market Impact - The emergence of ESR1 mutations as biomarkers for breast cancer has significantly increased global demand for rapid and sensitive assays in the oncology market [4] - The collaboration between Biodesix and Bio-Rad is expected to enhance access to sensitive biomarker detection for advanced breast cancer, addressing clinical needs with speed and precision [4] Upcoming Events - Both companies will present more details on their R&D visions, partnerships, and commercial roadmaps at the upcoming AMP conference scheduled for November 11-15 in Boston, MA [4]

Core Insights - The partnership between DataVault AI and Wellgistics aims to digitize the U.S. prescription drug market, valued at $634.32 billion, through blockchain-enabled smart contracts to enhance efficiency and transparency in drug distribution [1][2][3] Company Overview - DataVault AI specializes in AI-driven data experiences and monetization, leveraging patented technologies to innovate across various industries, including healthcare [4][5] - Wellgistics Health focuses on improving medication delivery from manufacturers to patients, utilizing an integrated platform that connects over 6,500 pharmacies and 200 manufacturers [6] Strategic Partnership - The collaboration will implement the PharmacyChain™ platform, which seeks to ensure accurate tracking of prescription drugs from the point of prescription to fulfillment, enhancing patient safety and compliance [1][2] - The companies plan to establish a revenue-sharing model based on fees from pharmacies utilizing the PharmacyChain technology [1][3] Technological Innovations - Wellgistics has introduced HubRx AI, an AI engine designed to optimize pharmacy operations, reduce costs, and improve patient outcomes while maintaining compliance with healthcare regulations [2][3] - The integration of various technological tools, including Einstein Rx AI and Wellgistics Hub, aims to enhance the overall efficiency of prescription drug services [2] Market Impact - The implementation of blockchain technology is expected to minimize administrative burdens, improve patient access to medications, and enhance the overall prescription ecosystem [3] - The partnership is positioned to create a scalable opportunity that aligns financial incentives with improved patient outcomes across the healthcare spectrum [2][3]

OKOTOKS, Alberta, Oct. 22, 2025 (GLOBE NEWSWIRE) -- (TSX: MTL) Mullen Group Ltd. ("Mullen Group", "We", "Our" and/or the "Corporation"), one of Canada's largest logistics providers today reported its financial and operating results for the period ended September 30, 2025, with comparisons to the same period last year. Full details of our results may be found within our Third Quarter Interim Report, which is available on the Corporation's issuer profile on SEDAR+ at www.sedarplus.ca or on our website at www. ...

Core Insights - The Verizon 2025 Mobile Security Index (MSI) indicates a significant increase in mobile attacks, with 85% of organizations reporting a rise in such incidents [1] - Organizations are responding by increasing mobile security spending, with 75% of them enhancing their security budgets over the past year [1] - The rise of generative AI (genAI) is expanding the attack surface, with 34% of organizations concerned about sophisticated AI-powered attacks and 38% fearing that AI will make ransomware more dangerous [1] Mobile Security Threat Landscape - The current environment is described as a "perfect storm" where AI-powered threats are more advanced, and human error remains a critical vulnerability [2] - A significant 39% of organizations found that up to half of their employees clicked on malicious links during smishing tests, highlighting the intersection of human behavior and mobile security risks [2] Organizational Response and Adaptation - The MSI serves as a wake-up call, emphasizing that mobile security is now a personal responsibility for every employee [3] - Organizations are urged to rethink their security measures in light of AI-assisted attacks and to support employees in using technology securely [3] SMBs vs. Large Enterprises - Small and medium-sized businesses (SMBs) feel disadvantaged in terms of resources, with 57% agreeing that they struggle more than larger enterprises to respond to cybersecurity threats [4] - 54% of SMBs believe they have more to lose from a security breach, a sentiment echoed by larger enterprises [4] - A notable 63% of organizations experienced major issues due to downtime, and 50% reported data loss as their top concern [4] Future Security Strategies - A unified approach to network and mobile security is essential for resilience against cyber threats [5] - Organizations are increasing their security spending and adopting a broader perspective on defense strategies [5] Evolving Threats and Defenses - Only 17% of businesses have specific security controls against AI-assisted attacks, which poses a significant risk as cybercriminals leverage genAI for more sophisticated attacks [7] - A staggering 93% of organizations report that employees use genAI on their mobile devices, with 64% identifying data compromise through genAI as their primary mobile risk [7] Training and Implementation - Organizations are focusing on training, with 66% planning to train more employees on mobile security compared to 56% of SMBs [8] - There is a push for more comprehensive AI risk training, with 50% of organizations implementing this compared to 39% of SMBs [8] - Advanced multifactor authentication is being adopted by 57% of organizations, while only 45% of SMBs are doing the same [8]

TORONTO, Oct. 22, 2025 (GLOBE NEWSWIRE) -- McEwen Inc. (NYSE/TSX: MUX) (“McEwen” or the “Company”) is pleased to report encouraging new results from its 2025 drilling program at Windfall, part of the Company’s Gold Bar Mine Complex, in the Eureka Mining District of Nevada. The drilling program at Windfall represents one of several initiatives currently underway by the Company to: 1) increase gold resources, 2) extend mine life and 3) lower production costs at the Gold Bar Mine. Windfall was acquired by McEw ...